Oliviero James F III's Form 4 filing
Checkpoint Therapeutics, Inc. (CKPT) · filed Apr 22, 2022
- Accession no.
- 0001104659-22-049156
- Filed
- Apr 22, 2022
- Trade date
- Jan 1-Apr 13, 2022
- Filing delay
- 111 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $211.5K. It was filed 111 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oliviero James F IIICIK 0001434718 | Director, Officer (CEO, President and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2022 | COMMON STOCK | FTax withholdingDisposed | −302,777 | $3.11 | −$941,636.47 | 3,305,433 | Direct | |
| Jan 6, 2022 | COMMON STOCK | FTax withholdingDisposed | −53,024 | $2.77 | −$146,876.48 | 3,252,409 | Direct | |
| Jan 24, 2022 | COMMON STOCK | FTax withholdingDisposed | −143,136 | $2.19 | −$313,467.84 | 3,109,273 | Direct | |
| Jan 30, 2022 | COMMON STOCK | FTax withholdingDisposed | −31,972 | $2.46 | −$78,651.12 | 3,077,301 | Direct | |
| Feb 24, 2022 | COMMON STOCK | FTax withholdingDisposed | −117,657 | $1.85 | −$217,665.45 | 2,959,644 | Direct | |
| Apr 4, 2022 | COMMON STOCK | SSaleDisposed | −86,353 | $1.79F3 | −$154,571.87 | 2,873,291 | Direct | |
| Apr 5, 2022 | COMMON STOCK | SSaleDisposed | −14,030 | $1.77F4 | −$24,833.1 | 2,859,261 | Direct | |
| Apr 13, 2022 | COMMON STOCK | SSaleDisposed | −21,258 | $1.51F5 | −$32,099.58 | 2,838,003 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.77 to $1.81. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.75 to $1.78. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.51 to $1.52. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.